Firms

Mitsui & Co. Global Investment, Inc.

Mitsui & Co. Global Investment, Inc.

Menlo Park, California, United States · Tokyo, Japan

mitsui-global.com

Mitsui & Co. Global Investment, Inc. (MGI) is the venture-investment subsidiary of Mitsui & Co., Ltd., investing in technology and life-sciences companies through its own investment partnerships. Established in 2001 as Mitsui & Co. Venture Partners, Inc., it adopted its current name in 2010. Its public offices include Menlo Park and Tokyo. MGI combines venture investing with the parent’s international industrial network; its portfolio includes healthcare AI, computational biology, ALS and neuropsychiatric drug development, neurological care, quantum-dot devices and industrial technologies. The current public team has 13 named investment, finance, administrative and advisory people. Some published functions explicitly relate to the separate E12 Ventures joint platform. E12 Fund I’s USD105M final commitments are not attributed as a directly managed MGI fund: its general partner is a separately constituted joint venture. Primary SEC filings identify legacy MCVP investment vehicles, whose fund sizes and close dates are undisclosed in the reviewed evidence. The parent company remains a separate investor identity.

Founded
—
Type
Venture capital

Funds2

  • MCVP Technology Fund I, LLC—

    Primary SEC-filed agreement explicitly signs MCVP Technology Fund I, LLC by Mitsui & Co. Global Investment, Inc., its manager. Delaware legal fund; fund commitments and exact closing date are not disclosed. Company investment and ownership values are not fund raises.

  • Mitsui & Co. Venture Partners III LLC—

    Primary issuer SEC proxy identifies this legacy MCVP investment vehicle, care of Mitsui & Co. Global Investment, Inc. Its ownership is reported alongside MCVP Technology Fund I. Historical affiliated investment vehicle; current active fundraising status, fund commitments and closing date are undisclosed.

Team

Operations and support

Caroline PinkneyCaroline PinkneyInvestor
Indri OngkoIndri OngkoCFO
Irene MingozziIrene MingozziVenture Partner (directory); Investment Principal (biography), MGI/E12
Kazufumi NakamuraKazufumi NakamuraInvestment Director
Kenjiro WatanabeKenjiro WatanabePresident & CEO
Loleta RobinsonLoleta RobinsonVenture Partner
Makiko KikuchiMakiko KikuchiFinance & Operations Coordinator
Masaya WatanabeInvestment Team (exact title unpublished)
Orie SchneiderOrie SchneiderExecutive Assistant & Office Manager
Paulina SzyzdekPaulina SzyzdekPrincipal — E12 Ventures affiliation
Reiko NamikawaReiko NamikawaVenture Partner
Toshihiro TeradaToshihiro TeradaPrincipal
Yukitaka KojimaYukitaka KojimaPrincipal

Co-investing

Amgen Ventures
Dementia Discovery Fund
Dolby Family Ventures
Droia Ventures
INKEF Capital

Investments

$45M2025-06-12Ellipsis HealthKhosla Ventures, Salesforce Ventures, CVS Health, AME Cloud Ventures, E12 Ventures, Mitsui & Co. Global Investment, Inc.
$133M2024-05-02Reunion NeuroscienceMPM BioImpact, Novo Holdings, Mitsui & Co. Global Investment, Inc., Palo Santo VC, FemHealth Ventures, Plaisance Capital Management, Arkin Bio Capital
$88M2023-03-09QurAlisDroia Ventures, EQT Life Sciences, Sanofi Ventures, INKEF Capital, Dementia Discovery Fund, Mission BioCapital, Polaris Innovation Fund, Amgen Ventures, ALS Investment Fund, Sanford Biosciences LLC, MP Healthcare Venture Management, Dolby Family Ventures, Mission Bay Capital, Mitsui & Co. Global Investment, Inc.
$42M2020-05-13QurAlisINKEF Capital, Dementia Discovery Fund, Mission BioCapital, Droia Ventures, Polaris Innovation Fund, Amgen Ventures, Sanford Biosciences LLC, MP Healthcare Venture Management, Dolby Family Ventures, Mitsui & Co. Global Investment, Inc.
$53M2014-12-02KaminarioSequoia, Silicon Valley Bank, Pitango VC, Tenaya Capital, Globespan Capital Partners, Mitsui & Co. Global Investment, Inc.
$—Unknown dateSvante TechnologiesMitsui & Co. Global Investment, Inc.
$40MUnknown dateSpireSeraphim Space, Qualcomm Ventures, RRE Ventures, ITOCHU Technology Ventures, Inc., Mitsui & Co. Global Investment, Inc., Expon Capital